Quarterly report pursuant to Section 13 or 15(d)

Other current liabilities

v3.23.1
Other current liabilities
3 Months Ended
Mar. 31, 2023
Other current liabilities  
Other Current Liabilities

4.  Other current liabilities

 

Other current liabilities were comprised of the following items:

 

 

 

March 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Interest and tax accrual

 

$ 1,448

 

 

$ 921

 

Equipment Purchase Accrual

 

 

724

 

 

 

724

 

ERC Commission Accrual

 

 

441

 

 

 

441

 

Excise and cannabis tax

 

 

278

 

 

 

948

 

Accrued Discounts and Promotions

 

 

125

 

 

 

97

 

Insurance and professional fee accrual

 

 

77

 

 

 

158

 

Third-party brand distribution accrual

 

 

46

 

 

 

17

 

Other

 

 

411

 

 

 

348

 

Total other current liabilities

 

$ 3,550

 

 

$ 3,654

 

 

On July 26, 2022, subsidiaries of the Company entered into an agreement with an institutional investor pursuant to which the investor purchased a participation ("Transferred Interests") in all rights to payment from the United States Internal Revenue Service in respect of the Company’s employee retention credits for the first and second quarters of 2021 (the “ERC Claim”). The purchase price paid for the derivative payment rights was $2.45 million, which was paid in immediately available funds. For the year ended December 31, 2022, the Company recorded net other income of $2,014 and an accrued other liability of $441 to be paid to facilitate the sale of the ERC Claim.